Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX228 in Adult Subjects With Type 1 Diabetes
NCT06474598Phase 2Recruiting
- Sponsor
- University of Alberta
- Start
- Nov 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolimidone in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Started Nov 2024; status: recruiting.
02
Drugs
tolimidone
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06474598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06474598.